General News

Global Hemostasis and Tissue Sealing Agents Industry 2019 | with Key Drivers, Industry Research, Regional Forecast, Top Players, Key Companies and Segment

The study provides the detail insights about the industry that comprise SWOT (Strength, Weakness, Opportunities, Threats) analysis, Value and Supply chain analysis, Porter Five forces (Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat Of Substitutes, Intense Rivalry), and the factor that drives and hamper the growth of market during forecast period. Also, the study provides an in-depth analysis of the various segments of the market. For more info click here @ https://www.reportocean.com/industry-verticals/sample-request?report_id=31992

The global Hemostasis and Tissue Sealing Agents market size are expected to be worth USD 6,632.9 million by 2026 growing at a CAGR of 7.8% from 2019 to 2026, as per new research report published by Polaris Market Research. The report on Global Hemostasis and Tissue Sealing Agents Market Size, Share, Trends & Industry Analysis, [By Product Type (Topical Hemostats, Adhesives & Tissue Sealing Agents); By End User; By Region]: Segment Forecast, 2019 – 2026, provides in-depth analysis of the current and upcoming market trends.

 

During 2017, among product types, Topical hemostats segment was observed to capture the largest market shares in terms of revenue. Among the regional markets, North America region accounted for a dominating share and the regional market in Asia Pacific is anticipated to witness fastest growth during the forecast period.

 

Increase in demand across the world for minimally invasive surgeries along with the continual rise in geriatric patients with chronic conditions are factors responsible for the estimated growth in this market. Also, as new hemostats and tissue sealants are being introduced in the market, they are witnessing increased preference as these products eliminate any issues and risks associated with tissue contamination.

 

hemostasis-tissue-sealing-agents-market

 

Moreover, injuries caused by sports activities, spinal conditions coupled with the growing emphasis on effective measures for blood loss management during surgeries are expected to have a further positive influence on the adoption of these products. The significant rate of growth in the amount of hospitals and surgical centers in markets of emerging economies present encouraging opportunities for manufacturers of hemostats and tissue sealant agents.

 

The regional analysis section in this report covers North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa regional markets. North America Hemostasis and Tissue Sealing Agents market held the leading position among all regional markets and is expected to maintain its dominating position throughout the forecast period. However, market in Asia Pacific region is expected to grow at the highest rate; the growth in this region is majorly expected due to rapidly improving healthcare infrastructure, rising medical tourism, and growing aging population in countries such as China and India. 

 

The FDA has approved fibrin sealants as broad level hemostats for use in surgical procedures. These are popular and conveniently used in Myocardial Infarction (MI) surgeries and specifically in cases of patients having clotting disorders. Major companies in the global hemostasis and tissue sealing agents market include Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Baxter International Inc., BD Bard, CryoLife, Inc., Ethicon, GELITA MEDICAL GmbH, Medtronic, Pfizer Inc., Smith & Nephew plc, and Stryker Corporation.

 

Polaris Market Research has segmented the global Hemostasis and Tissue Sealing Agents market on the basis of Product, End User and Region:

Hemostasis and Tissue Sealing Agents by Product Outlook (Revenue, USD Billion, 2015 – 2026)

    Topical Hemostats
    Active Hemostats
    Mechanical Hemostats
    Flowable Hemostats
    Adhesive and Tissue Sealing Agents
    Synthetic tissue sealant
    Natural tissue sealant
    Adhesion barrier products

Hemostasis and Tissue Sealing Agents by End User Outlook (Revenue, USD Billion, 2015 – 2026)

    Hospitals
    Ambulatory Surgical Centers
    Home Care Settings

Hemostasis and Tissue Sealing Agents by Region Outlook (Revenue, USD Billion, 2015 – 2026)

    North America
        U.S.
        Canada
    Europe
        Germany
        UK
        France
        Italy
        Spain
        Belgium
        Netherlands
    Asia Pacific
        China
        India
        Japan
        South Korea
        Australia
    Latin America
        Brazil
        Mexico
        Argentina
    Middle East and Africa
        South Africa

Complete Report Details @ https://www.reportocean.com/industry-verticals/sample-request?report_id=31992

Note: The study base year and forecast period can be customized as per the request. Also, the table of contents is the defined scope of a published report. As per requirement, cross-sectional analysis across all industries or specific geography or ‘country-based’ analysis can be provided as a part of customization

Table of Contents
1. Overview and Scope
1.1. Research goal & scope
1.2. Research assumptions
1.3. Research Methodology
1.3.1. Primary data sources
1.3.2. Secondary data sources
1.4. Key take-aways
1.5. Stakeholders
2. Executive Summary
2.1. Market Definition
2.2. Market Segmentation
3. Global Hemostasis and Tissue Sealing Agents Market Insights
3.1. Hemostasis and Tissue Sealing Agents – Industry snapshot
3.2. Hemostasis and Tissue Sealing Agents – Ecosystem analysis
3.3. Hemostasis and Tissue Sealing Agents – Market dynamics
3.3.1. Hemostasis and Tissue Sealing Agents – Market Forces
3.3.1.1. Hemostasis and Tissue Sealing Agents – Market driver analysis
3.3.1.2. Hemostasis and Tissue Sealing Agents – Market restraint/challenges analysis
3.3.1.3. Hemostasis and Tissue Sealing Agents – Market opportunity analysis
3.4. Industry analysis – Porter’s five force
3.4.1. Bargaining power of supplier
3.4.2. Bargaining power of buyer
3.4.3. Threat of substitute
3.4.4. Threat of new entrant
3.4.5. Degree of competition
3.5. Hemostasis and Tissue Sealing Agents market PEST analysis, 2017
3.6. Value Chain Analysis
3.7. Hemostasis and Tissue Sealing Agents Market Industry trends
4. Hemostasis and Tissue Sealing Agents Market Size and Forecast, 2018-2026 by Product Type
4.1. Key findings
4.2. Topical Hemostats
4.3. Active Hemostats
4.4. Mechanical Hemostats
4.5. Flowable Hemostats
4.6. Adhesives & Tissue Sealing Agents
4.7. Synthetic tissue sealant
4.8. Natural tissue sealant
4.9. Adhesion barrier products
5. Hemostasis and Tissue Sealing Agents Market Size and Forecast, 2018-2026 by End User
5.1. Key findings
5.2. Hospitals
5.3. Ambulatory Surgical Centers
5.4. Home Care Settings
6. Hemostasis and Tissue Sealing Agents Market Size and Forecast, 2018-2026 by Regions
6.1. Key findings
6.2. North America
6.2.1. U.S.
6.2.2. Canada
6.3. Europe
6.3.1. Germany
6.3.2. UK
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Belgium
6.4. Asia Pacific
6.4.1. China
6.4.2. India
6.4.3. Japan
6.4.4. South Korea
6.4.5. Australia
6.5. Latin America
6.5.1. Brazil
6.5.2. Mexico
6.6. Middle East & Africa
6.6.1. Israel
6.6.2. South Africa
7. Company Profiles
7.1. CryoLife Inc.
7.1.1. Overview
7.1.2. Financials
7.1.3. Products/Offerings
7.1.4. Recent Developments
7.2. Ethicon, Inc. (Johnson & Johnson Services, Inc.)
7.2.1. Overview
7.2.2. Financials
7.2.3. Products/Offerings
7.2.4. Recent Developments
7.3. Pfizer Inc.
7.3.1. Overview
7.3.2. Financials
7.3.3. Products/Offerings
7.3.4. Recent Developments
7.4. Advanced Medical Solutions Group plc
7.4.1. Overview
7.4.2. Financials
7.4.3. Products/Offerings
7.4.4. Recent Developments
7.5. BD Bard
7.5.1. Overview
7.5.2. Financials
7.5.3. Products/Offerings
7.5.4. Recent Developments
7.6. Medtronic (Covidien plc)
7.6.1. Overview
7.6.2. Financials
7.6.3. Products/Offerings
7.6.4. Recent Developments
7.7. Stryker Corporation (HyperBranch Medical Technology, Inc.)
7.7.1. Overview
7.7.2. Financials
7.7.3. Products/Offerings
7.7.4. Recent Developments
7.8. Smith & Nephew plc
7.8.1. Overview
7.8.2. Financials
7.8.3. Products/Offerings
7.8.4. Recent Developments
7.9. Mil Laboratories Pvt Ltd.
7.9.1. Overview
7.9.2. Financials
7.9.3. Products/Offerings
7.9.4. Recent Developments
7.10. Becton, Dickinson and Company.
7.10.1. Overview
7.10.2. Financials
7.10.3. Products/Offerings
7.10.4. Recent Developments
7.11. Braun Melsungen AG
7.11.1. Overview
7.11.2. Financials
7.11.3. Products/Offerings
7.11.4. Recent Developments
7.12. Baxter International Inc.
7.12.1. Overview
7.12.2. Financials
7.12.3. Products/Offerings
7.12.4. Recent Developments

Continue…

Get more information, Ask for free sample copy: https://www.reportocean.com/industry-verticals/sample-request?report_id=31992

Follow us on:

Facebook:          https://www.facebook.com/reportocean

Twitter:              https://twitter.com/reportocean

LinkedIn:            https://in.linkedin.com/company/reportocean

Contact: +1 888 212 3539 (US) +91-9997112116 (Outside US)
Contact Person: Sandeep Singh
Email: sales@reportocean.com

Tags